These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32449841)

  • 41. SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins.
    Reichel C; Gmeiner G; Reihlen P; Thevis M; Schänzer W
    Methods Mol Biol; 2019; 1855():131-149. PubMed ID: 30426415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of DNA concentration in urine and dried blood samples to detect the c.577 deletion within the EPO gene.
    Leuenberger N; Jan N; Kuuranne T; Castella V
    Drug Test Anal; 2024 Oct; 16(10):1225-1233. PubMed ID: 38247130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of c.577del in EPO: Investigations into endogenous EPO double-band detected in blood with SAR-PAGE.
    Zhou X; He S; Zezhou L; Jiayu W; Zhou W; Liu X; Zhao M; Zhang L
    Drug Test Anal; 2022 Apr; 14(4):622-633. PubMed ID: 34791828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New urinary EPO drug testing method using two-dimensional gel electrophoresis.
    Khan A; Grinyer J; Truong ST; Breen EJ; Packer NH
    Clin Chim Acta; 2005 Aug; 358(1-2):119-30. PubMed ID: 15907825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of de-N-glycosylated EPO with SDS-PAGE: A complementary confirmation procedure for recombinant EPO in blood samples.
    He S; Liu X; Wu D; Zhou X
    Drug Test Anal; 2022 Nov; 14(11-12):1974-1983. PubMed ID: 35603456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch
    Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control.
    Lasne F; Martin L; Martin JA; de Ceaurriz J
    Haematologica; 2009 Jun; 94(6):888-90. PubMed ID: 19483162
    [No Abstract]   [Full Text] [Related]  

  • 48. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates.
    Reihlen P; Völker-Schänzer E; Majer B; Schänzer W
    Drug Test Anal; 2012 Nov; 4(11):813-7. PubMed ID: 22566398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
    Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males.
    Athanasiadou I; Dokoumetzidis A; Voss SC; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
    J Pharm Sci; 2019 Jun; 108(6):2162-2172. PubMed ID: 30684541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of peptidic erythropoiesis-stimulating agents in sport.
    Reichel C
    Br J Sports Med; 2014 May; 48(10):842-7. PubMed ID: 24677025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of high-throughput IEF-PAGE for EPO-doping testing.
    Reichel C
    Drug Test Anal; 2012 Sep; 4(9):728-32. PubMed ID: 22991138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations?
    Lundby C; Robach P
    Eur J Appl Physiol; 2010 Jan; 108(1):197-200. PubMed ID: 19865825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
    Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A
    Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of EPO injections using a rapid lateral flow isoform test.
    Lönnberg M; Lundby C
    Anal Bioanal Chem; 2013 Dec; 405(30):9685-91. PubMed ID: 23657454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
    Bailly-Chouriberry L; Cormant F; Garcia P; Lönnberg M; Szwandt S; Bondesson U; Popot MA; Bonnaire Y
    Analyst; 2012 May; 137(10):2445-53. PubMed ID: 22454833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simple visualization method for the c.577del of erythropoietin variant: CRISPR/dCas9-based single nucleotide polymorphism diagnosis.
    Yi JY; Kim M; Jeon M; Min H; Kim BG; Son J; Sung C
    Drug Test Anal; 2024 Aug; 16(8):786-791. PubMed ID: 36610033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.